Aston University and pharmaceutical giant sign for medical future of Midlands
Aston University in Birmingham, UK has just signed a long-term agreement with pharmaceutical manufacturing giant, Mayne Pharma Plc , to run the first dedicated medical manufacturing clean room in the region.
The room will be used to produce specialist cancer and other drugs and make them available across the Midlands. This will address the particular need in the region for aseptic facilities to support the preparation of pharmaceuticals with a short shelf life - particularly in the treatment of children. In addition to this, the agreement - which was facilitated by Aston University’s Business Partnership Unit – will also create a unique opportunity for the West Midlands.
Guppy Dhariwal, Director of Finance and Business Services at Aston stated: “Aston University is delighted to be entering into this exciting new partnership. It will not only create new jobs in the region but it will, to the best of our knowledge, be the first manufacturing unit of its type that brings together high-quality university research with advanced pharmaceutical manufacturing techniques.”
The alliance will offer Aston University (which boasts the only pharmacy school in the region) and Mayne Pharma numerous collaborative opportunities, and will contribute directly to the University’s research and teaching in pharmacy.
John Edwards Chief Executive of Advantage West Midlands said: “Medical technologies is a growth industry in this region and we’re delighted to support Aston University in this exciting venture.”
The clean room provides an ultra clean, sterile and controlled environment for pharmaceutical manufacture, research and teaching and will offer a complete specialist environment to support the development of new medicines. Its rooms are temperature and humidity controlled to allow the aseptic production, manipulation and reconstitution of a variety of medical products (including chemotherapy drugs usually used in the treatment of cancer and individually tailored treatments for premature babies) that cannot be sterilised commercially.
Scott Richards, President, Mayne Pharma EMEA, said: “This is an important development for growing Mayne’s aseptic manufacturing business operations in the UK. Being located at such a research-focussed university as Aston in Birmingham, and so close to excellent transport links will enable us to offer outstanding levels of service for our customers in the Midlands whilst also supporting our wider UK business.”
Paul Burkwood | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...